Clinical Trial VICCTHO0136
Title
Molecular Fingerprinting of Lung Cancer (SPORE)
Principal Investigator(s)
Details
- Protocol No. VICCTHO0136
- Open Date: 05/01/2001
- Staging: NA
- Age Group: Adults
- Scope: Local
- Objective:
- Disease Sites: Non Small Cell
- Therapies: Correlative
- Drugs: None Specified
- Participating Institutions: Vanderbilt University; Veterans Administration; Meharry Medical College; St. Thomas Health Services
- National Clinical Trial ID: NCT00897117
- Secondary Protocol No: VICCTHO0136
Description
None Provided.
Eligibility
| Ages Eligible for Study: | 18 Years and older |
|---|---|
| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | No |
Criteria
Inclusion criteria
• Diagnosis of non-small cell lung cancer
• Clinical stage I and II disease
• Resectable disease and complete surgical resection planned
• Treated on companion studies at Vanderbilt University, the Veterans Administration hospital, St. Thomas, and Vanderbilt-Ingram Cancer Center Affiliate Network
• Tumor specimen samples must be available at resection
Exclusion criteria
• Chemotherapy before surgery
• Radiotherapy before surgery
Learn More
- Call toll-free number: 1-800-811-8480
- Use our Online self–referral form
- Print this page for your doctor
You do not have JavaScript enabled. This site works better with JavaScript turned on.
